NRT Smoking Cessation Aids - South Africa
As a result of trying economic times, increased cost of living and inflation, consumers in South Africa were increasingly keen to quit smoking as cigarettes were considered to be expensive. Luxury items are the first to be cut back on when there is financial difficulty and this trend drove growth in NRT smoking cessation aids in 2009.
Euromonitor International's NRT Smoking Cessation Aids Products in South Africa report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Euromonitor International's NRT Smoking Cessation Aids Products in South Africa report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Consumer Health industry;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Executive Summary
Steady Growth in Challenging Retail Environment
Self-medication Plays Major Role in Volume Sales
OTC Sales Dominated by A Small Number of Players
Grocery Channels Increase Footprint
Health Concerns at the Forefront of Consumers' Minds
Key Trends and Developments
In-store Pharmacies Expand Footprint
Recession Forces Companies To Increase Their Advertising Campaigns
Increased Self-medication Expands Untrustworthy Trade Footprint
Hiv/aids Symptoms and Side-effects Elevate OTC Sales
Growing Appeal for Natural/herbal Variants
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Penetration of Private Label by Sector 2004-2009
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
Summary 1 Consumer Health Switches in 2009
Definitions
Sector and Subsector Definitions
Summary 2 Research Sources
Adcock Ingram Ltd
Strategic Direction
Key Facts
Summary 3 Adcock Ingram Ltd: Key Facts
Summary 4 Adcock Ingram Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 5 Adcock Ingram Ltd: Competitive Position 2009
Aspen Pharmacare (pty) Ltd
Strategic Direction
Key Facts
Summary 6 Aspen Pharmacare (Pty) Ltd: Key Facts
Summary 7 Aspen Pharmacare (Pty) Ltd - SA Pharmaceutical Division: Operational Indicators2
Company Background
Production
Competitive Positioning
Summary 8 Aspen Pharmacare: Competitive Position 2009
Bioscience Brands Ltd
Strategic Direction
Key Facts
Summary 9 Bioscience Ltd: Key Facts
Summary 10 Bioscience Ltd: Number of employees
Company Background
Production
Competitive Positioning
Summary 11 Bioscience Brands (Pty) Ltd: Competitive Position 2009
Cipla-medpro (pty) Ltd
Strategic Direction
Key Facts
Summary 12 Cipla-Medpro (Pty) Ltd: Key Facts
Summary 13 Cipla-Medpro (Pty) Ltd Limited: Operational Indicators
Company Background
Production
Competitive Positioning
Dischem (pty) Ltd
Strategic Direction
Key Facts
Summary 14 Dis-Chem (Pty) Ltd: Key Facts
Company Background
Production
Competitive Positioning
Novartis South Africa (pty) Ltd
Strategic Direction
Key Facts
Summary 15 Novartis South Africa (Pty) Ltd: Key Facts
Company Background
Production
Competitive Positioning
Summary 16 Novartis South Africa (Pty) Ltd: Competitive Position 2009
Vital Health Foods (pty) Ltd
Strategic Direction
Key Facts
Summary 17 Vital Health Foods (Pty) Ltd: Key Facts
Company Background
Competitive Positioning
Summary 18 Vital Health Foods (Pty) Ltd: Competitive Position 2009
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Indicators
Table 12 Number of Smokers by Gender 2004-2009
Category Data
Table 13 Sales of Smoking Cessation Aids by Subsector: Value 2004-2009
Table 14 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2004-2009
Table 15 NRT Gum Flavours: % Value Breakdown 2006-2009
Table 16 Smoking Cessation Aids Company Shares by Value 2005-2009
Table 17 Smoking Cessation Aids Brand Shares by Value 2006-2009
Table 18 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2009-2014
Table 19 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2009-2014
Steady Growth in Challenging Retail Environment
Self-medication Plays Major Role in Volume Sales
OTC Sales Dominated by A Small Number of Players
Grocery Channels Increase Footprint
Health Concerns at the Forefront of Consumers' Minds
Key Trends and Developments
In-store Pharmacies Expand Footprint
Recession Forces Companies To Increase Their Advertising Campaigns
Increased Self-medication Expands Untrustworthy Trade Footprint
Hiv/aids Symptoms and Side-effects Elevate OTC Sales
Growing Appeal for Natural/herbal Variants
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Penetration of Private Label by Sector 2004-2009
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
Summary 1 Consumer Health Switches in 2009
Definitions
Sector and Subsector Definitions
Summary 2 Research Sources
Adcock Ingram Ltd
Strategic Direction
Key Facts
Summary 3 Adcock Ingram Ltd: Key Facts
Summary 4 Adcock Ingram Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 5 Adcock Ingram Ltd: Competitive Position 2009
Aspen Pharmacare (pty) Ltd
Strategic Direction
Key Facts
Summary 6 Aspen Pharmacare (Pty) Ltd: Key Facts
Summary 7 Aspen Pharmacare (Pty) Ltd - SA Pharmaceutical Division: Operational Indicators2
Company Background
Production
Competitive Positioning
Summary 8 Aspen Pharmacare: Competitive Position 2009
Bioscience Brands Ltd
Strategic Direction
Key Facts
Summary 9 Bioscience Ltd: Key Facts
Summary 10 Bioscience Ltd: Number of employees
Company Background
Production
Competitive Positioning
Summary 11 Bioscience Brands (Pty) Ltd: Competitive Position 2009
Cipla-medpro (pty) Ltd
Strategic Direction
Key Facts
Summary 12 Cipla-Medpro (Pty) Ltd: Key Facts
Summary 13 Cipla-Medpro (Pty) Ltd Limited: Operational Indicators
Company Background
Production
Competitive Positioning
Dischem (pty) Ltd
Strategic Direction
Key Facts
Summary 14 Dis-Chem (Pty) Ltd: Key Facts
Company Background
Production
Competitive Positioning
Novartis South Africa (pty) Ltd
Strategic Direction
Key Facts
Summary 15 Novartis South Africa (Pty) Ltd: Key Facts
Company Background
Production
Competitive Positioning
Summary 16 Novartis South Africa (Pty) Ltd: Competitive Position 2009
Vital Health Foods (pty) Ltd
Strategic Direction
Key Facts
Summary 17 Vital Health Foods (Pty) Ltd: Key Facts
Company Background
Competitive Positioning
Summary 18 Vital Health Foods (Pty) Ltd: Competitive Position 2009
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Indicators
Table 12 Number of Smokers by Gender 2004-2009
Category Data
Table 13 Sales of Smoking Cessation Aids by Subsector: Value 2004-2009
Table 14 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2004-2009
Table 15 NRT Gum Flavours: % Value Breakdown 2006-2009
Table 16 Smoking Cessation Aids Company Shares by Value 2005-2009
Table 17 Smoking Cessation Aids Brand Shares by Value 2006-2009
Table 18 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2009-2014
Table 19 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2009-2014